Novartis Ag (NVS) Change in Acquisitions & Divestments (2009 - 2026)

Novartis Ag has reported Change in Acquisitions & Divestments for 11 years, with the latest figure at $218.0 million in Q2 2026.

• Quarterly Change in Acquisitions & Divestments rose 7366.67% year-over-year to $218.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $302.0 million (up 1178.57% YoY) and the FY2025 annual result came in at -$24.0 million, down 242.86% from the prior year.
• Change in Acquisitions & Divestments grew to $218.0 million in Q2 2026 per NVS's latest filing, from -$3.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $2.1 billion in Q2 2022 and troughed at -$958.0 million in Q3 2024.
• A 5-year average of $207.1 million and a median of $43.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 14233.33% in 2024, down 581.41% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $12.0 million in 2022, then surged by 166.67% to $32.0 million in 2023, then jumped by 2825.0% to $936.0 million in 2024, then plunged by 94.87% to $48.0 million in 2025, then surged by 354.17% to $218.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $218.0 million, -$3.0 million, and $48.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.